Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease

被引：0

作者：

Malo de Molina, Rosa ^{[1
]}

Restrepo, Marcos I. ^{[2
,3
]}

Mortensen, Eric M. ^{[2
,4
]}

Izquierdo, Jose L. ^{[5
]}

Anzueto, Antonio ^{[2
,3
]}

机构：

[1] Hosp Univ Puerta Hierro Majadahonda, Dept Pulm Med, Madrid, Spain

[2] South Texas Vet Hlth Care Syst, VERDICT Res Unit, San Antonio, TX USA

[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Dept Pulm & Crit Care Med, San Antonio, TX USA

[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Gen Internal Med, San Antonio, TX USA

[5] Hosp Univ Guadalajara, Dept Pulm Med, Guadalajara, Spain

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2010年 / 6卷 / 03期

关键词：

Chronic obstructive pulmonary disease; pneumonia; inhaled corticosteroids;

D O I：

10.2174/157339810791526229

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Inhaled corticosteroids (ICS) have been recommended for use in patients with chronic obstructive pulmonary disease (COPD) in order to decrease exacerbation rates and improve health related quality of life parameters. Nevertheless, recent studies have reported an increased risk of pneumonia associated with this treatment. However, most studies were not specifically designed to detect pneumonia as a possible secondary effect and for this reason it is difficult to determine whether this risk exists and assess its magnitude. This paper reviews the published studies reporting pneumonia events in COPD patients treated with ICS.

引用

页码：162 / 166

页数：5

共 50 条

[31] Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease
Pujades-Rodriguez, M.
Smith, Q. P.
Hubbard, R. B.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (08) : 509 - 517
[32] Are inhaled corticosteroids systemic therapy for chronic obstructive pulmonary disease?
Calverley, P
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (07) : 721 - 722
[33] Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease Reply
Drummond, M. Bradley
Fan, Eddy
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (14): : 1433 - 1434
[34] Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Benefits and Risks
Mkorombindo, Takudzwa
Dransfield, Mark T.
CLINICS IN CHEST MEDICINE, 2020, 41 (03) : 475 - 484
[35] Benefits and Risks of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Marcel Bonay
Catherine Bancal
Bruno Crestani
Drug Safety, 2002, 25 : 57 - 71
[36] Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease
Glaab, Thomas
Taube, Christian
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (01) : 15 - 22
[37] ELEVATED PLGF PREDICTING PNEUMONIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING INHALED CORTICOSTEROIDS THERAPY
Cheng, Shih-Lung
Wang, Hao-Chien
Kuo, Sow-Hsong
RESPIROLOGY, 2010, 15 : 97 - 97
[38] Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease A Nationwide Cohort Study
Lee, Ming-Chia
Lee, Chih-Hsin
Chien, Shu-Chen
Chang, Jer-Hwa
She, Han-Lin
Wang, Jann-Yuan
Yu, Ming-Chih
MEDICINE, 2015, 94 (42) : e1723
[39] Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kew, Kayleigh M.
Seniukovich, Alieksei
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
[40] Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease
Lee, TA
Weiss, KB
Sullivan, SD
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (08): : 618 - 618

← 1 2 3 4 5 →